C07D 227/06
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D227/06 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 45 US grants and 24 published applications in this corpus.
Search patents in C07D- Granted patents
- 45
- Published applications
- 24
- Assignees
- 35
- Inventors
- 116
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 0 |
| 2014 | 0 | 3 |
| 2015 | 1 | 2 |
| 2016 | 3 | 1 |
| 2017 | 0 | 3 |
| 2018 | 4 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 3 |
| 2024 | 0 | 2 |
| 2025 | 2 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Compounds for the treatment of SARS11 Nov 2025US 12,466,792 B2Purdue Research Foundation
- Compounds for the treatment of SARS11 Nov 2025US 12,466,793 B2Purdue Research Foundation
- Compounds for the treatment of SARS5 Dec 2023US 11,834,408 B2Purdue Research Foundation
- Compounds and uses thereof for the modulation of hemoglobin20 Dec 2022US 11,530,191 B2Global Blood Therapeutics, Inc.
- Compounds and uses thereof for the modulation of hemoglobin10 Nov 2020US 10,829,470 B2Global Blood Therapeutics, Inc.
- Compounds for the treatment of sars18 Apr 2024US 2024/0124395 A1Purdue Research Foundation
- Compounds for the treatment of sars11 Apr 2024US 2024/0116865 A1Purdue Research Foundation
- Compounds and uses thereof for the modulation of hemoglobin12 Oct 2023US 2023/0322704 A1Global Blood Therapeutics, Inc.
- Inhibitor of vapor space polymerization5 Oct 2023US 2023/0312477 A1Ecolab USA Inc.
- Substituted bicyclic and tricyclic ureas and amides, analogues thereof, and methods using same6 Apr 2023US 2023/0108906 A1Arbutus Biopharma Corporation
Most cited
By later US patents
- Compounds and uses thereof for the modulation of hemoglobin50US 9,422,279 B2Global Blood Therapeutics, Inc. · 2016
- Compounds and uses thereof for the modulation of hemoglobin34US 10,017,491 B2Global Blood Therapeutics, Inc. · 2018
- Lactam-N-acetic acids and their amides17US 4,221,789 AUCB, Societe Anonyme · 1980
- Compounds and uses thereof for the modulation of hemoglobin17US 9,981,939 B2Global Blood Therapeutics, Inc. · 2018
- Lactamimide inhibitors of gastrointestinal hypersecretion16US 4,061,746 ARichardson-Merrell Inc. · 1977